Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Resonance Health Ltd ( (AU:RHT) ) has issued an update.
Resonance Health Ltd announced a change in the director’s interest notice, specifically regarding Simon Panton. The announcement detailed that Simon Panton, through entities controlled by him and his wife, acquired additional ordinary fully paid shares, increasing his indirect interest in the company. This change reflects an on-market trade and signifies a potential vote of confidence in the company’s future prospects by a key stakeholder.
The most recent analyst rating on (AU:RHT) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Resonance Health Ltd stock, see the AU:RHT Stock Forecast page.
More about Resonance Health Ltd
Resonance Health Ltd operates in the healthcare industry, focusing on providing medical imaging software and services. The company is known for its specialized products that assist in the diagnosis and management of human diseases, particularly in liver health.
Average Trading Volume: 317,257
Technical Sentiment Signal: Hold
Current Market Cap: A$21.83M
See more data about RHT stock on TipRanks’ Stock Analysis page.